CS logo
small CS logo
Community Howard Regional Health

Kokomo, Indiana, United States
Hospital in Kokomo, Indiana
3500 S Lafountain St, Kokomo, IN 46902
152 Beds

About Community Howard Regional Health


Community Howard Regional Health is a hospital located in Kokomo, Indiana, USA, and is part of the Community Health Network group of hospitals in Indiana.
There are 152 beds in Community Howard Regional Health.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
76
Alliance for Clinical Trials in Oncology
74
SWOG Cancer Research Network
17
Gynecologic Oncology Group
16
Eastern Cooperative Oncology Group
15
ECOG-ACRIN Cancer Research Group
11
NSABP Foundation Inc
11
Radiation Therapy Oncology Group
6
GOG Foundation
4
ETOP IBCSG Partners Foundation
2
Canadian Cancer Trials Group
1
Total Rows: 14

Clinical Trials at Community Howard Regional Health


During the past decade, Community Howard Regional Health conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 140 clinical trials were completed, i.e. on average, 933.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 26 clinical trials were completed. i.e. 2600% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1155440044111818131347471717191999Started TrialsCompleted Trails2015201620172018201920200204060
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
1999-12-01
Completed
515
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
1998-10-01
Completed
571
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
2000-01-01
2010-03-01
Terminated
589
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571

Rows per page:

1–100 of 236

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Community Howard Regional Health" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "Alliance for Clinical Trials in Oncology" with 74 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "Gynecologic Oncology Group" with 16 trials sponsored and "Eastern Cooperative Oncology Group" with 16 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Community Howard Regional Health" #1 collaborator was "National Cancer Institute (NCI)" with 157 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 34 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 76National CancerInstitute (NCI): 76Alliance for ClinicalTrials in Oncology: 74Alliance for ClinicalTrials in Oncology: 74SWOG Cancer ResearchNetwork: 17SWOG Cancer ResearchNetwork: 17Gynecologic OncologyGroup: 16Gynecologic OncologyGroup: 16Eastern CooperativeOncology Group: 15Eastern CooperativeOncology Group: 15ECOG-ACRIN CancerResearch Group: 11ECOG-ACRIN CancerResearch Group: 11NSABP Foundation Inc: 11NSABP Foundation Inc: 11Radiation TherapyOncology Group: 6Radiation TherapyOncology Group: 6GOG Foundation: 4GOG Foundation: 4ETOP IBCSG PartnersFoundation: 2ETOP IBCSG PartnersFoundation: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 157National CancerInstitute (NCI): 157NRG Oncology: 24NRG Oncology: 24Cancer and LeukemiaGroup B: 13Cancer and LeukemiaGroup B: 13NCIC Clinical Trials Group: 13NCIC Clinical Trials Group: 13SWOG Cancer ResearchNetwork: 12SWOG Cancer ResearchNetwork: 12Eastern CooperativeOncology Group: 9Eastern CooperativeOncology Group: 9North Central CancerTreatment Group: 8North Central CancerTreatment Group: 8Canadian Cancer Trials Group: 4Canadian Cancer Trials Group: 4Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Genentech, Inc.: 3Genentech, Inc.: 3

Clinical Trials Conditions at Community Howard Regional Health


According to Clinical.Site data, the most researched conditions in "Community Howard Regional Health" are "Breast Cancer" (40 trials), "Lung Cancer" (18 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (16 trials), "Colorectal Cancer" (12 trials) and "Lymphoma" (12 trials). Many other conditions were trialed in "Community Howard Regional Health" in a lesser frequency.

Clinical Trials Intervention Types at Community Howard Regional Health


Most popular intervention types in "Community Howard Regional Health" are "Drug" (192 trials), "Other" (128 trials), "Biological" (81 trials), "Procedure" (40 trials) and "Radiation" (35 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (60 trials), "Quality-of-Life Assessment" (38 trials), "placebo" (34 trials), "Paclitaxel" (28 trials) and "Bevacizumab" (24 trials). Other intervention names were less common.

Clinical Trials Genders at Community Howard Regional Health


The vast majority of trials in "Community Howard Regional Health" are 160 trials for "All" genders, 67 trials for "Female" genders and 9 trials for "Male" genders.

Clinical Trials Status at Community Howard Regional Health


Currently, there are NaN active trials in "Community Howard Regional Health". undefined are not yet recruiting, 9 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 135 completed trials in Community Howard Regional Health, undefined suspended trials, and 20 terminated clinical trials to date.
Out of the total trials that were conducted in Community Howard Regional Health, 7 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 128 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 128Phase 3: 128Phase 2: 87Phase 2: 87Phase 1: 7Phase 1: 7Not Applicable: 6Not Applicable: 6

Created with Highcharts 11.1.0Trials StatusCompleted: 135Completed: 135Active, not recruiting: 65Active, not recruiting: 65Terminated: 20Terminated: 20Recruiting: 9Recruiting: 9Unknown status: 7Unknown status: 7

Departments of Community Howard Regional Health


Community Howard Regional Health has several departments that took part in Clinical trials: "Community Heart and Vascular Hospital" - 8 trials
Departments List
Name
City
Trials
Total Rows: 1